The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Overactive Bladder Treatment Market Research Report 2025
Synopsis
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
The global Overactive Bladder Treatment market was valued at US$ 5100 million in 2023 and is anticipated to reach US$ 6287.9 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.
This report aims to provide a comprehensive presentation of the global market for Overactive Bladder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Overactive Bladder Treatment.
Report Scope
The Overactive Bladder Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Overactive Bladder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Overactive Bladder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical
Segment by Type
Drugs
Device
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Overactive Bladder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
The global Overactive Bladder Treatment market was valued at US$ 5100 million in 2023 and is anticipated to reach US$ 6287.9 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.
This report aims to provide a comprehensive presentation of the global market for Overactive Bladder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Overactive Bladder Treatment.
Report Scope
The Overactive Bladder Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Overactive Bladder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Overactive Bladder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical
Segment by Type
Drugs
Device
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Overactive Bladder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Overactive Bladder Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drugs
1.2.3 Device
1.3 Market by Application
1.3.1 Global Overactive Bladder Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Overactive Bladder Treatment Market Perspective (2019-2030)
2.2 Overactive Bladder Treatment Growth Trends by Region
2.2.1 Global Overactive Bladder Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Overactive Bladder Treatment Historic Market Size by Region (2019-2024)
2.2.3 Overactive Bladder Treatment Forecasted Market Size by Region (2025-2030)
2.3 Overactive Bladder Treatment Market Dynamics
2.3.1 Overactive Bladder Treatment Industry Trends
2.3.2 Overactive Bladder Treatment Market Drivers
2.3.3 Overactive Bladder Treatment Market Challenges
2.3.4 Overactive Bladder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Overactive Bladder Treatment Players by Revenue
3.1.1 Global Top Overactive Bladder Treatment Players by Revenue (2019-2024)
3.1.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Overactive Bladder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Overactive Bladder Treatment Revenue
3.4 Global Overactive Bladder Treatment Market Concentration Ratio
3.4.1 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Treatment Revenue in 2023
3.5 Overactive Bladder Treatment Key Players Head office and Area Served
3.6 Key Players Overactive Bladder Treatment Product Solution and Service
3.7 Date of Enter into Overactive Bladder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Overactive Bladder Treatment Breakdown Data by Type
4.1 Global Overactive Bladder Treatment Historic Market Size by Type (2019-2024)
4.2 Global Overactive Bladder Treatment Forecasted Market Size by Type (2025-2030)
5 Overactive Bladder Treatment Breakdown Data by Application
5.1 Global Overactive Bladder Treatment Historic Market Size by Application (2019-2024)
5.2 Global Overactive Bladder Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Overactive Bladder Treatment Market Size (2019-2030)
6.2 North America Overactive Bladder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Overactive Bladder Treatment Market Size by Country (2019-2024)
6.4 North America Overactive Bladder Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Overactive Bladder Treatment Market Size (2019-2030)
7.2 Europe Overactive Bladder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Overactive Bladder Treatment Market Size by Country (2019-2024)
7.4 Europe Overactive Bladder Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Overactive Bladder Treatment Market Size (2019-2030)
8.2 Asia-Pacific Overactive Bladder Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Overactive Bladder Treatment Market Size (2019-2030)
9.2 Latin America Overactive Bladder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Overactive Bladder Treatment Market Size by Country (2019-2024)
9.4 Latin America Overactive Bladder Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Overactive Bladder Treatment Market Size (2019-2030)
10.2 Middle East & Africa Overactive Bladder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Overactive Bladder Treatment Introduction
11.1.4 Allergan Revenue in Overactive Bladder Treatment Business (2019-2024)
11.1.5 Allergan Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Overactive Bladder Treatment Introduction
11.2.4 Astellas Pharma Revenue in Overactive Bladder Treatment Business (2019-2024)
11.2.5 Astellas Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Overactive Bladder Treatment Introduction
11.3.4 Pfizer Revenue in Overactive Bladder Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Overactive Bladder Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Overactive Bladder Treatment Introduction
11.5.4 Medtronic Revenue in Overactive Bladder Treatment Business (2019-2024)
11.5.5 Medtronic Recent Development
11.6 KYORIN Pharmaceutical
11.6.1 KYORIN Pharmaceutical Company Detail
11.6.2 KYORIN Pharmaceutical Business Overview
11.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Introduction
11.6.4 KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2019-2024)
11.6.5 KYORIN Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
